|1.||Montefiori, David C: 5 articles (04/2015 - 07/2005)|
|2.||Moss, Bernard: 4 articles (04/2015 - 02/2010)|
|3.||Kozlowski, Pamela A: 4 articles (04/2015 - 02/2010)|
|4.||Amara, Rama Rao: 4 articles (04/2015 - 12/2010)|
|5.||Lifson, Jeffrey D: 4 articles (01/2013 - 07/2005)|
|6.||Piatak, Michael: 4 articles (01/2013 - 07/2005)|
|7.||Franchini, Genoveffa: 3 articles (11/2014 - 01/2004)|
|8.||Robinson, Harriet L: 3 articles (11/2012 - 12/2010)|
|9.||Vincent, Amy L: 3 articles (03/2011 - 11/2007)|
|10.||Janke, Bruce H: 3 articles (03/2011 - 11/2007)|
09/01/1998 - "Despite evidence that live, attenuated simian immunodeficiency virus (SIV) vaccines can elicit potent protection against pathogenic SIV infection, detailed information on the replication kinetics of attenuated SIV in vivo is lacking. "
02/01/2012 - "Thus, the results of the nonhuman primate (NHP) study described here recapitulate the lack of protection against HIV acquisition seen in the Step Trial and suggest a greater risk of infection in the Ad5-seropositive animals immunized with the Ad5 SIV vaccine. "
08/01/2012 - "The data suggest that the SPV-based recombinant vector expressing HA1 of H3N2 SIV might serve as a promising SIV vaccine for protection against SIV infection."
04/26/2012 - "Our data demonstrated that the recombinant swinepox virus encoding HA1 of SIV H1N1 may serve as a promising SIV vaccine for protection against SIV infection."
11/18/2009 - "The objective of this study was to assess the effect of concurrent infection with porcine reproductive and respiratory syndrome virus (PRRSV) on the efficacy of an inactivated swine influenza virus (SIV) vaccine. "
06/01/2014 - "Using a regimen of peptide priming followed by a modified vaccinia Ankara (MVA) boost in a nonhuman primate model, we found that an SIV vaccine incorporating molecular adjuvants mediated partial protection against rectal SIVmac251 challenges. "
01/26/2004 - "Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques."
01/26/2004 - "The ability of ALVAC- or fowlpox-based simian immunodeficiency virus (SIV) vaccines to boost SIV-specific CD4+ and CD8+ T-cell responses was tested in 10 vaccinia-experienced macaques infected with SIVmac251. "
08/01/1999 - "In fact, a live, recombinant SIV vaccine constructed using the attenuated pox virus vector modified vaccinia Ankara (MVA) elicited a high-frequency CTL response, comparable in magnitude to that elicited by SIV infection itself. "
12/15/2010 - "In this study, we investigate the effect of preexisting vaccinia virus immunity on the immunogenicity and efficacy of a DNA/modified vaccinia Ankara (MVA) SIV vaccine in rhesus macaques using a pathogenic intrarectal SIV251 challenge. "
|3.||Acquired Immunodeficiency Syndrome (AIDS)
05/27/1995 - "One of the few bright prospects in AIDS research is the findings from a study of an attenuated SIV vaccine in monkeys. "
01/24/2003 - "A live attenuated SIV vaccine strain, termed SIVmac239Delta3 and containing large deletions in, and the negative regulatory element, was previously shown to cause AIDS mostly in monkeys vaccinated as infants. "
08/01/2002 - "This first comprehensive report of Env peptide-specific Th responses associated with attenuated SIV vaccine immunity indicates a profound influence of glycosylation on the development of Th responses and has important implications for acquired immunodeficiency syndrome (AIDS) vaccine development."
01/02/1998 - "SIV vaccine for AIDS."
03/01/1990 - "Nevertheless, recent data in the SIV vaccine model give reason for encouragement that a state of protective immunity can be achieved in AIDS-like illness caused by retroviruses. "
|4.||HIV Infections (HIV Infection)
12/01/2011 - "Because cytotoxic T-lymphocytes (CTLs) have been shown to play a role in controlling human immunodeficiency virus (HIV) infection and because CTL-based simian immunodeficiency virus (SIV) vaccines have proved effective in non-human primates, one goal of HIV vaccine design is to elicit effective CTL responses in humans. "
|1.||A-Form DNA (A-DNA)
|2.||DNA (Deoxyribonucleic Acid)
|7.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)